Parallel Advisors, LLC Atrion Corp Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$381.09 - $495.99 $1,524 - $1,983	4 New	4 $1,000
Q4 2023 Feb 09, 2024	SELL	$289.29 - $409.7 $1,446 - $2,048	-5 Reduced 55.56%	4 $1,000
Q3 2023 May 20, 2024	BUY	$401.2 - $581.79 $2,808 - $4,072	7 Added 350.0%	9 $3,000
Q3 2023 Nov 13, 2023	BUY	$401.2 - $581.79 $2,808 - $4,072	7 Added 350.0%	9 $3,000
Q2 2023 May 20, 2024	BUY	$500.0 - $659.0 $1,000 - $1,318	2 New	2 $1,000
Q2 2023 Aug 04, 2023	BUY	$500.0 - $659.0 $1,000 - $1,318	2 New	2 $1,000
Q2 2022 Aug 01, 2022	SELL	$605.0 - $763.25 $23,595 - $29,766	-39 Reduced 86.67%	6 $4,000
Q1 2022 Apr 28, 2022	BUY	$601.4 - $763.0 $1,804 - $2,289	3 Added 7.14%	45 $32,000
Q4 2021 Jan 20, 2022	SELL	$650.15 - $802.0 $9,102 - $11,228	-14 Reduced 25.0%	42 $30,000
Q3 2021 Nov 02, 2021	BUY	$594.24 - $758.0 $23,769 - $30,320	40 Added 250.0%	56 $39,000
Q2 2021 Aug 06, 2021	BUY	$582.88 - $670.99 $4,663 - $5,367	8 Added 100.0%	16 $10,000
Q1 2021 Apr 23, 2021	SELL	$619.2 - $736.0 $21,052 - $25,024	-34 Reduced 80.95%	8 $5,000
Q4 2020 Feb 02, 2021	SELL	$576.6 - $672.2 $20,181 - $23,527	-35 Reduced 45.45%	42 $27,000
Q3 2020 Oct 27, 2020	BUY	$620.1 - $689.89 $27,284 - $30,355	44 Added 133.33%	77 $48,000
Q2 2020 Jul 16, 2020	BUY	$610.05 - $713.9 $11,590 - $13,564	19 Added 135.71%	33 $21,000
Q1 2020 Apr 27, 2020	BUY	$615.5 - $751.4 $3,077 - $3,757	5 Added 55.56%	14 $9,000
Q4 2019 Jan 30, 2020	SELL	$688.5 - $846.15 $4,131 - $5,076	-6 Reduced 40.0%	9 $7,000
Q3 2019 Nov 01, 2019	BUY	$722.04 - $840.0 $8,664 - $10,080	12 Added 400.0%	15 $12,000
Q2 2019 Aug 05, 2019	BUY	$837.83 - $927.0 $2,513 - $2,781	3 New	3 $3,000

Others Institutions Holding ATRI

# of Institutions

Shares Held

114K

Call Options Held

Put Options Held

View Full List

About ATRION CORP

Ticker ATRI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 1,785,990
Description
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...

More about ATRI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account